Long-term combination chemotherapy using eribulin and trastuzumab for three patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
Crossref DOI link: https://doi.org/10.1007/s13691-016-0253-y
Published Online: 2016-06-21
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Saeki, Toshiaki
Araki, Kazuhiro
Shimada, Ken
Shigekawa, Takashi
Nakayama, Hirofumi
Segawa, Yoshihiko
Mukai, Hirofumi
Funding for this research was provided by:
Eisai
License valid from 2016-06-21